HLA-C*01 and HLA-B*44 are potential molecular determinants in evaluating an individual’s risk of COVID-19, and genotyping of class I and II HLA in COVID-19 patients can identify individuals at a higher risk of a cytokine storm [62]. Here, HLA-C is linked to COVID-19.